Leiden University Medical Center

A recent study from Clinical Pharmacology & Therapeutics has upended the conventional understanding of how cannabidiol (CBD) interacts with tetrahydrocannabinol (THC), suggesting that CBD may actually enhance, rather than mitigate, the effects of THC. This revelation is quite the opposite of...

Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) has set up a clinical research program for the treatment of strokes, focused on its proprietary DMT analogue, AP-188. The company is also planning to begin a Phase 1 clinical trial in 2022’s fourth quarter. The decision to focus research on...